Spinal Muscular Atrophy
On this page:
At the Atkinson Morley Neuromuscular Centre at St George’s Hospital we run a specialist clinic for the diagnosis and treatment of Spinal Muscular Atrophy (SMA). We treat patients holistically working with a multi-disciplinary team of clinicians and allied health professionals in neurology, neurorehabilitation and respiratory medicine.
We are an NHS England treatment centre for Nusinersen (trade name Spinraza™), a genetic therapy for SMA. Patients referred to the clinic with SMA will have a multi-disciplinary assessment from a Consultant Neurologist, Specialist Neuromuscular Physiotherapist and Occupational Therapist to determine if Nusinersen is the right treatment for them.
If treatment with Nusinersen is planned you will be admitted to the neurosciences ward (Kent Ward) for pre-treatment assessments and the treatment will be delivered the next day with support from consultant colleagues in Interventional Radiology. The first dose is the start of treatment (called day 0) and doses are then repeated at day 14, day 28 and day 63. Maintenance doses are then required every 4 months with clinical assessments to determine the benefit of the treatment for you.
See our Frequently Asked Questions (FAQs) below regarding treatment with Nusinersen
Who you might meet
Neurology team members of the SMA multi-disciplinary team include:
Dr. Clare Galtrey, Consultant Neurologist
Dr Emma Matthews, Consultant Neurologist
Dr Niran Nirmalananthan, Consultant Neurologist
Dr Catherine Dalton, Consultant in Neurorehabilitation
Ms Pamela Appleton, Neuromuscular Care Advisor
Ms Sherryl Chatfield, Neuromuscular Physiotherapist
Ms Chloe Adjetey, Neuromuscular Coordinator
Dr Declan Johnson, Consultant Neuroradiologist
Respiratory team members include:
Dr Nicola Walters, Consultant in Respiratory and General medicine
Dr Susannah Leaver, Consultant Intensive Care and Respiratory Medicine
Samantha Prigmore, Respiratory Nurse Consultant
Sara Parsons, Consultant Clinical Scientist
We are happy to receive referrals from both GPs (via ERS) and secondary care. Please address new referrals to Dr Clare Galtrey.
For any queries please contact the Neuromuscular Co-ordinator on 0208 725 3291 or via email at email@example.com
FAQs about Nusinersen Treatment
- I wish to be considered for nusinersen treatment at St George’s – what should I do?
If you are already under the care of a Consultant Neurologist at St George’s please contact that consultant and ask to be referred to Dr Clare Galtrey for consideration of treatment for Nusinersen
If you are under a different neuromuscular centre or not currently attending a neuromuscular centre please ask your GP to refer you to Dr Clare Galtrey at St Georges including your contact details and location of previous neuromuscular care centre or place of diagnosis.
We will then contact you to arrange a consultation that may be via the telephone or video initially. Then you will need to attend a face to face appointment for full medical and physiotherapy assessment to determine if Nusinersen treatment is right for you.
We aim to make initial contact with you in 4-6 weeks.
- How is COVID affecting assessments and treatment?
- We are making initial consultations via the telephone or video to assess the next steps and avoid unnecessary visits to hospital
- During face to face appointments staff will wear appropriate PPE
- We can arrange patient transport for patients in our local catchment area of South West London and Surrey.
- Treatment will be done from Kent Ward, our neurosciences ward. This is classed as a Green ward which means all patients are required to self isolate for 14 days and have a negative COVID swab before admission.
- Where can I go for more information?